AG
DXCM icon

Ascent Group’s DexCom DXCM Stock Holding History

Ascent Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$782K Buy
12,447
+748
+6% +$52.1K 0.03% 414
2025
Q4 		$776K Buy
11,699
+491
+4% +$31.7K 0.03% 414
2025
Q3 		$754K Buy
11,208
+944
+9% +$74.7K 0.03% 409
2025
Q2 		$896K Buy
10,264
+899
+10% +$70.5K 0.03% 355
2025
Q1 		$640K Buy
9,365
+676
+8% +$55.2K 0.03% 401
2024
Q4 		$676K Buy
8,689
+739
+9% +$54.7K 0.05% 327
2024
Q3 		$533K Buy
7,950
+583
+8% +$47.9K 0.04% 366
2024
Q2 		$835K Buy
7,367
+1,072
+17% +$136K 0.07% 293
2024
Q1 		$873K Buy
6,295
+222
+4% +$27.9K 0.08% 292
2023
Q4 		$719K Buy
6,073
+1,047
+21% +$107K 0.07% 296
2023
Q3 		$464K Buy
5,026
+71
+1% +$8K 0.05% 325
2023
Q2 		$546K Sell
4,955
-1,474
-23% -$178K 0.06% 302
2023
Q1 		$747K Buy
6,429
+1,530
+31% +$171K 0.08% 265
2022
Q4 		$555K Buy
4,899
+121
+3% +$13.3K 0.07% 290
2022
Q3 		$577K Buy
4,778
+98
+2% +$8.3K 0.07% 270
2022
Q2 		$384K Buy
4,680
+364
+8% +$33.2K 0.05% 350
2022
Q1 		$552K Buy
4,316
+584
+16% +$63.9K 0.06% 282
2021
Q4 		$394K Buy
+3,732
New +$536K 0.05% 340

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ascent Group's DXCM Position: Q1 2026 in Review

Ascent Group increased its DexCom (DXCM) stake by 6.4% in Q1 2026, buying an estimated $52.1K and bringing the position to 12,447 shares worth $782K. The position accounts for 0.03% of the portfolio, ranked #414.

Ascent Group first reported a position in DXCM in Q4 2021 and has held it in 18 quarters since. The position peaked at $896K in Q2 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Ascent Group held 12,447 shares of DexCom worth $782K as of Q1 2026.
  • Ascent Group bought 748 DexCom shares in Q1 2026, an estimated $52.1K.
  • DexCom made up 0.03% of Ascent Group's portfolio in Q1 2026, its #414 holding.
  • Ascent Group first reported a position in DexCom in Q4 2021 and has held it in 18 quarters since.
  • Ascent Group's DexCom position peaked at $896K in Q2 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Ascent Group's 13F filing for Q1 2026, filed 15 May 2026.